|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Head and Neck Cancer | |||||
| 2 | Additional conditions recognized in this trial | ||||
| Head and Neck Neoplasms | |||||
| 3 | More general conditions related to this trial | ||||
| Neoplasms | |||||
| Neoplasms by Site | |||||
| 4 | Interventions listed in this trial | ||||
| amifostine trihydrate | |||||
| cisplatin | |||||
| fluorouracil | |||||
| radiation therapy | |||||
| surgical procedure | |||||
| 5 | Additional drug interventions recognized in this trial | ||||
| Amifostine | |||||
| 6 | More general drug interventions related to this trial | ||||
| Antimetabolites | |||||
| Antimetabolites, Antineoplastic | |||||
| Antineoplastic Agents | |||||
| Immunologic Factors | |||||
| Immunosuppressive Agents | |||||
| Molecular Mechanisms of Pharmacological Action | |||||
| Pharmacologic Actions | |||||
| Physiological Effects of Drugs | |||||
| Protective Agents | |||||
| Radiation-Protective Agents | |||||
| Therapeutic Uses | |||||
| 7 | Sponsors listed in this trial | ||||
| University of Pennsylvania | |||||